Functional analysis of retinitis pigmentosa 2 (RP2) protein reveals variable pathogenic potential of disease-associated missense variants by Patil, Suresh B et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Functional analysis of retinitis pigmentosa 2 (RP2) protein
reveals variable pathogenic potential of disease-associated
missense variants
Citation for published version:
Patil, SB, Hurd, TW, Ghosh, AK, Murga-Zamalloa, CA & Khanna, H 2011, 'Functional analysis of retinitis
pigmentosa 2 (RP2) protein reveals variable pathogenic potential of disease-associated missense variants'
PLoS One, vol. 6, no. 6, pp. e21379. DOI: 10.1371/journal.pone.0021379
Digital Object Identifier (DOI):
10.1371/journal.pone.0021379
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
PLoS One
Publisher Rights Statement:
Copyright: © 2011 Patil et al. This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Functional Analysis of Retinitis Pigmentosa 2 (RP2)
Protein Reveals Variable Pathogenic Potential of
Disease-Associated Missense Variants
Suresh B. Patil1,2, Toby W. Hurd3, Amiya K. Ghosh2,3, Carlos A. Murga-Zamalloa2,4, Hemant Khanna1,2*
1Department of Ophthalmology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America, 2Department of Ophthalmology and
Visual Sciences, University of Michigan, Ann Arbor, Michigan, United States of America, 3Department of Pediatrics and Communicable Diseases, University of Michigan,
Ann Arbor, Michigan, United States of America, 4Department of Pathology, University of Michigan, Ann Arbor, Michigan, United States of America
Abstract
Genetic mutations are frequently associated with diverse phenotypic consequences, which limits the interpretation of the
consequence of a variation in patients. Mutations in the retinitis pigmentosa 2 (RP2) gene are associated with X-linked RP,
which is a phenotypically heterogenic form of retinal degeneration. The purpose of this study was to assess the functional
consequence of disease-associated mutations in the RP2 gene using an in vivo assay. Morpholino-mediated depletion of rp2
in zebrafish resulted in perturbations in photoreceptor development and microphthalmia (small eye). Ultrastructural and
immunofluorescence analyses revealed defective photoreceptor outer segment development and lack of expression of
photoreceptor-specific proteins. The retinopathy phenotype could be rescued by expressing the wild-type human RP2
protein. Notably, the tested RP2 mutants exhibited variable degrees of rescue of rod versus cone photoreceptor
development as well as microphthalmia. Our results suggest that RP2 plays a key role in photoreceptor development and
maintenance in zebrafish and that the clinical heterogeneity associated with RP2 mutations may, in part, result from its
potentially distinct functional relevance in rod versus cone photoreceptors.
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Introduction
Recent advances in whole genome sequencing and exome
capture techniques have exploded the field of identification of new
disease in patients with genetic diseases [1,2]. However, even
patients with mutations in the same gene frequently exhibit
immense clinical heterogeneity, ranging from early-onset disorders
to relative less severe late onset disease. Such phenomena pose a
challenge to computationally predict and interpret the effect of the
mutation on the penetrance and severity of disease phenotypes.
Degeneration or dysfunction of photoreceptors is frequently
associated with variable clinical presentation, likely due to their
unique structure and metabolic demands [3]. Photoreceptors are
polarized neurons with a distinct inner segment (IS) and
photoreceptive outer segment (OS), linked by a narrow bridge-like
microtubule-rich structure, called connecting cilium [3]. Proteins,
such as rhodopsin, destined for outer segments are synthesized in
the IS and are transported via trans-Golgi network to the base of
cilium from where they are transported apically by microtubule-
based motor assemblies [4]. Additionally, there is passive motor-
independent bidirectional transport of some phototransduction
proteins [5,6,7]. Owing to high degree of protein trafficking
demands, dysfunction in protein synthesis, sorting or trafficking
results in photoreceptor dysfunction and degenerative disorders [8].
Retinitis Pigmentosa (RP) represents one such disorder that
exhibits both clinical and genetic heterogeneity in patients [9]. RP
is characterized by progressive loss of rod and cone photoreceptors
of the retina, resulting in night blindness followed by complete
blindness [10,11,12]. To date, more than 200 RP-associated genes
have been identified. RP is inherited in autosomal dominant,
recessive as well as X-lined manner [13]. X-linked RP is one of the
severe forms of RP, phenotypically characterized by onset of night
blindness in the second decade of life that progresses into legal
blindness by the age of 40 [14,15]. There are six genetic loci and
only two cloned genes for XLRP: retinitis Pigmentosa GTPase
regulator and retinitis Pigmentosa 2 (RP2). While mutations in
RPGR account for 70–80% of XLRP, RP2 mutations are known
to occur in approximately 20% of XLRP patients [16,17,18].
The RP2 gene (NM_006915.2)encodes a polypeptide of 350
amino acids [19]. Previous biochemical and cell biological studies
have revealed a potential role for RP2 in maintaining Golgi
cohesion and targeting of proteins to plasma membrane [20,21,22].
Some disease-associated mutations in RP2 abolish plasma mem-
brane targeting of RP2 in cultured cells. The amino-terminal region
(151 amino acids) of RP2 shares homology with tubulin-specific
chaperone protein (TBCC) and also acts as a potential GTPase
activating protein (GAP) for small GTPase ADP-ribosylation factor
like-3 (ARL3) [23,24,25,26]. The carboxyl-terminus of RP2 is
homologous of nucleoside diphosphate kinase (NDK); however, the
physiological function of this domain remains to be determined. We
have recently shown that RP2 localizes to sensory cilia and interacts
with polycystin-2, a protein involved in renal ciliary diseases [27].
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We and others have reported the association of wide-spectrum
of clinical phenotype in patients with RP2 mutations. These
clinical features include severe to late-onset disease, typical RP, as
well as macular dystrophy [18,28,29]. Disease causing mutations
in RP2 are presented in the form of splice site, missense, nonsense
and/or frameshift variations in the coding region. These
mutations seem to affect distinct protein interactions, likely due
to their effect on RP2 localization or interaction with other
proteins. Hence, detailed analysis of effect of RP2 mutations on its
function should provide insights into associated disease progression
and pathogenesis.
It has been shown that analysis of zebrafish embryos provides an
excellent platform to analyze in vivo effect of silencing of genes
followed by disease progression and pathogenesis [30,31].
Moreover, rescue of the phenotypes by human mRNA provides
an analytical assay system to ascertain the effect of disease-
associated mutations on the function of the protein, which in turn,
can provide novel insights into associated patient phenotype. In
the present study, we have utilized zebrafish as a platform to assess
the pathogenic potential of selected RP-associated disease
mutations in RP2. Our results indicate potentially distinct effects
of RP2 mutation on cone versus rod photoreceptor dysfunction,
the heterogeneity frequently observed in RP2 patients.
Results
Suppression of rp2 in zebrafish results in retinopathy
To gain insight into RP2 function, we first sought to determine
the localization of RP2 in zebrafish photoreceptors. Using a
previously reported anti-RP2 antibody [27], we found that RP2 is
expressed in both rod and cone photoreceptors, as determined by
staining with photoreceptor markers Zpr3 (rods) and Zpr1 (specific
to cone surface epitope on red green double cones) antibodies
(Figure 1A). These findings are consistent with the reported rod
Figure 1. RP2 is expressed in zebrafish photoreceptors. A. Retinal cryosections from 4 dpf zebrafish embryos were analyzed by
immunofluorescence using anti-Rp2 antibody (green). Photoreceptor markers, Zpr1 and Zpr3 (red) were used to stain cone and rod photoreceptors,
respectively. Arrows in Merge indicate co-localization (yellow) of RP2 with both markers. Nuclei are marked with Hoechst (blue). RPE: retinal
pigmented epithelium; OS: outer segment; IS: inner segment; ONL: outer nuclear layer; OPL: outer plexiform layer. B. Protein extracts from 4 dpf
zebrafish embryos injected with standard negative control (SNC) morpholino (MO) or rp2-MO were analyzed by SDS-PAGE and immunoblotting using
anti-RP2 antibody. The expected size band of 42 kDa was detected in the SNC-treated embryo extracts but not in the rp2-MO treated ones. Lower
panel shows immunoblotting of same samples using anti-b actin antibody, as loading control. C. Immunofluorescence analysis of cryosections of SNC
and rp2-mo treated embryo retina (4 dpf) was performed using anti-RP2 antibody (green). Merge with Nomarski image shows that the expression of
RP2 was significantly down regulated in the rp2-MO treated embryos.
doi:10.1371/journal.pone.0021379.g001
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and cone degeneration phenotypes observed in patients with RP2
mutations. To ascertain the effect of knockdown of rp2 function,
we designed a translation blocking (AUG) morpholino against the
zebrafish rp2 gene (NM_213446.1) and injected into 2–4 cells stage
wild-type (WT) zebrafish embryos [27]. We used 5 ng as an
optimal concentration, based on a survival curve to derive the
concentration of the MO to achieve maximal phenotype with
minimal lethality [27] (data not shown). Knockdown of RP2
protein expression was validated by immunoblotting and immu-
nohistochemistry (Figure 1B, C). RP2 protein expression can be
detected in standard negative control (SNC) MO injected embryos
but not in rp2-MO injected embryos (Figure 1B). Immunofluores-
cence analysis further corroborated these findings, as indicated by
a lack of detection of RP2-associated signal in the zebrafish
embryo retina in MO-injected fish (Figure 1C).
As RP2 mutations cause retinal degeneration in patients, we
utilized retinal degeneration phenotype as a read out for the effect
of silencing of the rp2 gene in zebrafish. Our analysis revealed that
suppression of rp2 in zebrafish results in microphthalmia (small
eye) (,15% of defective embryos) and abnormal photoreceptor
development in a majority (,90%) of embryos, although retinal
development seemed to proceed normally, at least up to 5 dpf.
However, injection of higher doses of the rp2-MO resulted in
defective retinal lamination (data not shown). Measurement of the
eye diameters on the histological sections indicated approximately
32% reduction in size of defective embryo eyes compared to
control embryos compared (1.10 mm60.01 in control eyes and
0.74 mm60.04 in defective embryo eyes; p,0.005) (Table 1).
Histological analysis of zebrafish retinas at 4 days post
fertilization (dpf) further revealed very few to no outer segment
development in the defective embryos (Figure 2A, C). Disruption
of OS development was further validated by electron microscopy
analysis (Figure 2D). To test cell death, we performed TUNEL
staining on control and defective embryo retinas at 3, 4, and 5 dpf.
We found that, at 4 dpf, total number of TUNEL positive cells was
statistically higher (38%) than control retinas (12%) (Figure 2E, F).
Similar increase in TUNEL positive cells in defective embryos was
observed at 3 and 5 dpf, indicating that silencing of rp2 results in
early developmental defects in zebrafish embryos (data not shown).
We next investigated the effect of depletion of rp2 on the
expression and localization of photoreceptor-specific proteins in
the embryo retinas. To this end, we performed immunofluores-
cence analysis of control and rp2-MO treated 4 dpf embryo retina
using Zpr1 and Zpr3 antibodies. As shown in Figure 2G, H,
suppression of rp2 results in a loss of both rod and cone
photoreceptor specific staining pattern, which also indicates a
defect in photoreceptor morphology (Figure 2G, H), consistent
with electron microscopy results. Similar results were obtained
when immunofluorescence was performed using anti-Rhodopsin
(1D4; rod specific opsin) or peanut agglutinin (PNA; cone cell
marker) (Figure S1). There seemed to be a consistently more
pronounced effect of rp2 depletion on Zpr1 staining compared to
Zpr3, which indicates a distinct role of RP2 in cone photoreceptor
formation and maintenance.
Human RP2-encoding mRNA rescues the rp2-MO
associated phenotype
As human and zebrafish RP2 genes are highly conserved [27],
we hypothesized that human RP2 mRNA can complement the loss
of RP2 in zebrafish. To this end, we performed rescue experiments
by co-injecting human RP2 mRNA with rp2-MO. The mRNA
was engineered to encode RP2 protein fused to GFP (green
fluorescent protein) at its carboxyl-terminus. We found that the
human mRNA could efficiently rescue the retinopathy phenotype
associated with suppression of rp2, whereas mRNA encoding GFP
alone did not result in a rescue. Histological and immunofluores-
cence analyses revealed preservation of photoreceptor morphology
and expression of rod and cone-specific proteins in the retina of
embryos treated with mRNA encoding RP2-GFP fusion protein.
As shown in Figure 3A, B, while the rp2-MO treated embryos
injected with mRNA encoding GFP alone did not show OS
development and expression of Zpr1 or Zpr3 (Figure 3B), injection
of mRNA encoding RP2-GFP fusion protein resulted in the
development of OS and expression of photoreceptor specific
proteins (red signal in Figure 3A, C). Consistently, we detected
expression of GFP or RP2-GFP proteins in the treated retinas
(Figure 3B and C).
Human RP2 mutations exhibit diverse pathogenic
potential
As the human RP2 mRNA could rescue the rp2-MO associated
retinopathy phenotype, we utilized the rp2-MO zebrafish as an
assay system to investigate the pathogenic potential of selected
nonsynonymous amino acid variations observed in patients. The
rationale for selecting nonsynonymous variations is that prediction
power of the effect of changes in the amino acid sequence on the
three-dimensional structure of the protein is limited by the in silico
algorithms. Additionally, if a protein possesses enzymatic activity,
as is in this case, single amino acid variations can result in mild to
adverse effect on the function depending upon the resultant
affinity for the substrate or activity towards the substrate.
We selected seven nonsynonymous RP2 variations reported in
patients that encompassed the GAP domain and the NDK-like
domain (Figure 4A). As the proteins are expressed as a fusion with
GFP, the expression levels of the different mutant proteins were
compared to the extent of the rescue of Zpr protein expression
achieved in the treated photoreceptors. We utilized three
parameters to assess the pathogenicity of the RP2 mutants: (i)
microphthalmia, (ii) histological analysis of retina, and (iii)
expression of Zpr1 and Zpr3 in photoreceptors. Co-injection of
mRNA encoding the selected RP2 variants with rp2-MO revealed
a spectrum of phenotypic rescue. While RP2 R118H and RP2
E138G resulted in eye diameter that was comparable to that with
WT RP2, other mutants did not seem to achieve a rescue of the
microphthalmia in defective embryos (Table 1). Mutants RP2
Table 1. Diameters of the zebrafish eye.
Injection of embryos Mean±S.E.
WT RP2 1.1960.015
SNC 1.1060.014
rp2-MO 0.7460.046
rp2-MO+GFP 0.6560.008
rp2-MO+RP2 GFP 1.1360.023
rp2-MO+C86Y-GFP 0.6760.015
rp2-MO+P95L -GFP 0.6460.015
rp2-MO+C108G- GFP 0.8560.037
rp2-MO+ R118H-GFP 1.0060.027
rp2-MO+ E138G-GFP 1.1060.024
rp2-MO+L188P-GFP 0.7060.011
rp2-MO+ R282WGFP 0.6560.022
doi:10.1371/journal.pone.0021379.t001
Pathogenic Potential of RP2 Human Mutations
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P95L, RP2 C108G and RP2 L188P although exhibited partial
rescue of photoreceptor morphology, as observed by formation of
photoreceptor OS, did not seem to completely complement the
expression of Zpr1 and Zpr3 (Figure 4). On the other hand,
mutants RP2 C86Y, RP2 R118H and RP2 E138G revealed
interesting observations. While the photoreceptor morphology and
levels of Zpr protein expression achieved with the C86Y mutation
were comparable to that obtained with GFP alone (Figure 4B, I),
the R118H mutation exhibited statistically significant rescue of
Zpr1 expression (,50% compared to GFP alone) (Figure 4E, I).
However, the R118H mutation behaved as a null allele in the
context of rod photoreceptor-specific Zpr3 expression (Figure 4E,
I). On the other hand, RP2 E138G exhibited partial complemen-
tation of RP2 function in rod photoreceptors (Zpr3 expression) but
not in cone photoreceptors (Figure 4F, I). One notable observation
was the lack of rescue observed with the RP2 R282W mutation
Figure 2. Silencing of rp2 results in retinopathies in zebrafish. A & C. Histological analysis of zebrafish retina treated with SNC (A) or rp2-MO
(D) was performed at 4 dpf. Insets show enlarged image of the area marked in white square. B & D. Electron microscopy analysis of SNC (B) and rp2-
MO (D) treated embryo retinas shows defective OS development due to knockdown of rp2. Right panels are higher magnification images of the left
panels. E. TUNEL staining of the indicated zebrafish retinas was performed using manufacturer’s instructions. Green nuclei indicate pycknotic cells.
The TUNEL staining was quantified and represented in panel F. *: p,0.001. G, H. SNC and rp2-MO treated embryo retina cryosections were stained
with Zpr1 and Zpr3 antibodies (red; arrows). Nuclei were stained with Hoechst (blue). OS: outer segment; IS: inner segment; ONL: outer nuclear layer;
INL: inner nuclear layer.
doi:10.1371/journal.pone.0021379.g002
Pathogenic Potential of RP2 Human Mutations
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(Figure 4H). This variation was reported as a polymorphism in one
study. However, for potential reasons discussed later, our results
suggest that this nonsynonymous variation renders the RP2
protein partially inactive.
Discussion
The complexity associated with diverse clinical features of a
disease due to mutations in a single gene has hampered our ability
to predict the degree of severity of the phenotype as well as the cell
types that are prone to dysfunction and degeneration. As RP2 is
proposed to function as an activator of small GTPase ARL3 and
may be involved in membrane trafficking, it is critical to examine
the effects of mutations in photoreceptors. As photoreceptors are
one of the highly metabolically active neurons and involve
immense transport of proteins from the inner to the photosensory
outer segments, even slight perturbations in protein trafficking
machinery results in photoreceptor degeneration and blindness
[32,33,34]. Our results indicate that involvement of rod versus
cone photoreceptors in RP2-associated retinopathy depend upon
the specific protein interactions and signaling pathways that are
affected by a particular mutation in the RP2 gene.
Figure 3. HumanWT RP2 can rescue rp2-MO associated phenotype. A. Histological analysis of retinas from embryos co-injected with rp2-MO
and mRNA encoding GFP (left panel; rp2-MO + GFP) or wild type (WT) RP2-GFP fusion protein (right panel; rp2-MO + RP2-GFP). OS: outer segment; IS:
inner segment; ONL: outer nuclear layer; OPL: outer plexiform layer. B and C. Immunofluorescence analysis of the indicated embryo retinas was
performed using Zpr1 or Zpr3 antibodies (red; arrows) or anti-GFP antibodies (green). Hoechst was used to stain nuclei (blue). OS: outer segment; IS:
inner segment; ONL: outer nuclear layer; INL: inner nuclear layer; GCL: ganglion cell layer.
doi:10.1371/journal.pone.0021379.g003
Pathogenic Potential of RP2 Human Mutations
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Figure 4. RP2 disease mutations exhibit diverse pathogenic potential. A. Schematic representation of the primary structure of the RP2
protein and predicted domains. Arrows indicate the mutations tested in this study. GAP: GTPase activating protein domain. B–H. Histological and
immunofluorescence analyses (using ZPR1 or ZPR3 antibodies; red; arrows or anti-GFP; green) of retinas of embryos injected with rp2-MO and mRNA
encoding indicated RP2 mutant proteins (fused to GFP) was performed as described in the Methods section. Nuclei are stained with Hoechst (blue).
RPE: retinal pigmented epithelium; OS: outer segment; IS: inner segment; ONL: outer nuclear layer; INL: inner nuclear layer; GCL: ganglion cell layer. I.
Quantitative analysis of ZPR1 and ZPR3 expression in the photoreceptor layer of the different embryos was performed and compared to expression of
the WT or mutant RP2-GFP protein. The results are represented as ratio of Zpr1 or Zpr3 expression to the GFP expression in photoreceptors.
doi:10.1371/journal.pone.0021379.g004
Pathogenic Potential of RP2 Human Mutations
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In this report, we have analyzed the functional consequence of
mutations in RP2 on its function using in vivo approaches. The
use of zebrafish as an experimental platform has distinct
advantages, as it shares common developmental and morpholog-
ical characteristics with higher vertebrates, including humans [35].
Additionally, the zebrafish model provides an excellent assay
system to examine physiologically relevant phenotypes, including
retinal development and degeneration [30,36,37]. These are
particularly relevant to assessing the pathogenic potential of
mutations that have a relatively low frequency of occurrence and
are not amenable to traditional genotype-phenotype correlation
studies. Our studies provide an assay system to functionally
correlate the effect of disease-causing mutations of RP2 to disease
progression. In our analysis, the RP2-C86Y mutant protein could
not completely rescue the ZPR1 as well as ZPR3 expression,
indicating a dysfunction of both cone and rod photoreceptors. On
the other hand, a common disease-associated RP2 variant R118H
exhibited partial rescue of Zpr1 staining but not of Zpr3. The
R118H mutation results in reduced affinity of RP2 for ARL3 and
is associated with severe photoreceptor degeneration in some
patients [26,29]. On the other hand, the E138G mutation seems to
partly rescue the rod photoreceptor-associated phenotype. Recent
studies showed that the residue Glu 138 is involved in its
association with NSF, a protein involved in membrane trafficking
[22]. It is however, possible that residues Arg118 and Glu138 are
involved in additional ARL3- and NSF-independent roles,
respectively. Further studies are needed to dissect such roles.
It was intriguing to note that the R282W variation revealed
dysfunction of RP2 in both rod and cone photoreceptors. This is
particularly surprising since R282W was initially identified as a
polymorphism and was observed in control population albeit at
low frequency [18]. We speculate that this mutation may be
detrimental to RP2 function and affect its interaction or
intracellular localization but does not, by itself, retain a pathogenic
potential. Sequence alterations in other genes may be required for
the complete penetrance and severity of the retinal degeneration
phenotype. This hypothesis is supported by our previous report
that a hypomorphic allele of RPGRIP1L, A229T, although affects
protein function in zebrafish rescue assays, is frequently associated
with retinal degeneration in patients with founder mutation in a
different gene [37].
Notably, our data seem to be consistent with previously reported
observations of pathogenicity of RP2 mutations in patients. We
found a spectrum of severity associated with RP2 mutations, as
revealed by different degree of rescue of cone versus rod
photoreceptor development. These results suggest that context-
dependent function of RP2 in photoreceptors should be considered
when analyzing disease pathogenesis. Moreover, our studies
corroborate the clinical findings of RP2 patients that exhibit classic
RP as well as macular atrophy starting at an early age [29]. We do
acknowledge that the role of RP2 in photoreceptor development in
zebrafish embryos may not extrapolate to human condition. This is
because RP2 patients, based on clinical features and age of onset of
disease, do not exhibit a photoreceptor developmental anomaly. In
addition, there is a lack of evidence of any RP2 patients exhibiting
extra-retinal phenotypes. Abnormal developmental defects ob-
served in this study could be reminiscent of the zebrafish system
wherein a multi-system developmental anomaly may depend upon
the degree of knockdown of gene expression. The mutant RP2
proteins tested in this study were able to partly rescue the
developmental phenotype observed due to knockdown of rp2.
Thus, these RP2 mutations may be hypomorphic in nature.
However, involvement of species-specific regulators of protein
expression and function cannot be ruled out at this stage. Studies are
underway to generate mammalian models of RP2 dysfunction that
would be amenable to designing rational therapeutic approaches.
Materials and Methods
Ethics statement
All animal procedures were approved under the protocol
A2221-10 titled ‘‘Retinal degeneration due to defective protein
trafficking in photoreceptors’’ by our Institutional Animal Care
and Use Committee of the University of Massachusetts Medical
School, which operates under approval number A-3306-01 from
the Association of Assessment and Accreditation of Laboratory
Animal Care (AAALAC).
Antibodies
Rabbit anti-RP2 antibody was generated by immunizing rabbits
with full length recombinant human GST-RP2 and characterized
for specificity, as described [27]. Mouse anti-acetylated a-tubulin
and rabbit anti-actin antibodies were obtained from Sigma (Sigma
Aldrich, St. Louis, MO). Alexa 564 was obtained from Invitrogen
(Carlsbad, CA). Zpr1 and Zpr3 were purchased from www.Zfin.
org. Rhodopsin 1D4 antibody was a kind gift of Dr. Robert S.
Molday.
Histology, immunofluorescence, and ultrastructural
analyses
Histological analysis on zebrafish retina was performed on JB4
plastic sections as previously described [38]. Paraformaldehyde
fixed embryo were analyzed for immunofluorescence as described
earlier. Electron Microscopy was done using standard protocols.
Briefly, zebrafish were fixed in perfused with 4% paraformalde-
hyde and 2.5% glutaraldehyde in PBS. The fish were treated with
osmium tetroxide and dehydrated using graded ethanol series
followed by treatment with propylene oxide and embedded in
Epon-812 resin. Gold interference (50–80nM) sections mounted
on grids were post stained uranyl acetate (5% in ethanol), and lead
citrate (4% aqueous solution), washed with water and dried before
imaging under Philips C10 TEM at 80 KV.
Morpholino mediated knockdown and capped RNA
synthesis
To knock down zebrafish RP2, we synthesized a translation
blocking morpholino (Gene-Tools) (AUG-MO 59,GGCCTG-
TCAGCATAA.3’’) [27]. A standard mismatch morpholino (Gene
tools) was used as negative control. To rescue the MO-induced
phenotype, the zebrafish RP2 gene was cloned into pEGFP-N1
(Clonetech) vector and mutations were created using QuickChange
mutagenesis kit (Stratagene). Capped mRNAwas synthesized in vitro
with mMessenger mMachine T7 kit (Ambion).
Zebrafish phenotype analysis
Zebrafish (Danio rerio) were reared and maintained as previously
described [31]. Embryos were analyzed at 4 dpf for tail extension
anomalies hydrocephaly, curved tails, edema, pericardial effusion
and micro-ophthalmic phenotypes. The effect of various mutants
mRNA was assessed as percent defective embryo compared to
morpholino alone. Fluorescence intensity was analyzed on
cryosections using Leica Application Suite and results were
expressed as ratio of intensities for Zpr1 or Zpr3 to GFP.
Supporting Information
Figure S1 RP2 is expressed in both rod and cone
photoreceptors. Immunofluorescence analysis of 4 dpf zebra-
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fish embryos injected SNC-MO and rp2-MO was performed using
anti-rhodopsin (1D4) antibody or PNA (red). Nuclei are stained
with DAPI (blue). RPE: retinal pigmented epithelium; OS: outer
segment; IS: inner segment; ONL: outer nuclear layer; INL: inner
nuclear layer; GCL: ganglion cell layer.
(TIF)
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